Drugmakers Suspend Autoimmune Trials After Fatalities
Trials by Novartis and Bristol Myers have been paused, prompting investigations into why a promising autoimmune treatment has become risky. The halt highlights concerns over safety issues related to the therapy.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading